Today: 19 May 2026

Microsoft stock steadies near $385 as AI spending worries set the tone for MSFT

Microsoft stock steadies near $385 as AI spending worries set the tone for MSFT

Microsoft shares rose 0.2% to $385.28 in early Tuesday trading after a 3.2% drop the previous session. Bridgewater Associates estimated Big Tech could spend $650 billion on AI infrastructure this year, warning of downside risk. Investors are watching Nvidia’s earnings Wednesday for signals on AI demand. Microsoft CEO Satya Nadella is scheduled to speak at a Morgan Stanley conference on March 4.
24 February 2026
········
Micron stock price rises as chip trade steadies ahead of Nvidia earnings

Micron stock price rises as chip trade steadies ahead of Nvidia earnings

Micron shares rose about 1.5% to $427.08 in early Tuesday trading, rebounding after a tariff-driven selloff. Investors focused on AI hardware demand and upcoming Nvidia results, while broader markets stayed flat. AMD announced a $60 billion AI chip deal with Meta, lifting chip sentiment. Tariff uncertainty and supply constraints continued to weigh on the sector.
24 February 2026
······
SanDisk stock steadies after Citron short call; SNDK traders watch next catalysts

SanDisk stock steadies after Citron short call; SNDK traders watch next catalysts

Sandisk shares rose 1.3% to $675.19 Tuesday morning after Citron Research disclosed a short position and warned the NAND chip shortage could end quickly. The stock dipped briefly after Citron’s post before rebounding. Citron cited rising competition, especially from Samsung, as a risk. Investors are watching Sandisk’s conference appearances starting Feb. 25 for updates.
24 February 2026
··
Aeromexico stock price today: AERO rises after Mexico airport disruption update

Aeromexico stock price today: AERO rises after Mexico airport disruption update

Grupo Aeromexico shares rose 1.1% to $19.05 after the airline said it was restoring flights at four western Mexico airports disrupted by recent violence. Major carriers, including American and United, had suspended flights after cartel-related attacks. Aeromexico expects regular schedules to resume by Tuesday, noting limited impact on its network. Mexico’s main stock index fell 0.36% in early trading.
24 February 2026
··
Datadog stock slides in early trade as Anthropic’s AI security tool keeps investors wary

Datadog stock slides in early trade as Anthropic’s AI security tool keeps investors wary

Datadog shares fell 1.3% to $101.24 in early Tuesday trading after AI startup Anthropic launched Claude Code Security, a tool targeting software vulnerabilities. Other cybersecurity stocks and IBM also dropped sharply Monday on similar concerns. Datadog recently beat Q4 estimates with $953.2 million in revenue and forecast Q1 revenue of $951–$961 million. A Form 144 filing showed insider Alexis T. LeQuoc proposed selling 21,612 shares.
24 February 2026
···
Varonis stock rebounds after 11% slide as fresh shareholder lawsuit filing hits tape

Varonis stock rebounds after 11% slide as fresh shareholder lawsuit filing hits tape

Varonis Systems shares rose about 2.4% to $21.59 Tuesday morning after plunging 11% the previous day. A law firm said a securities class action was filed for investors who bought between Feb. 4 and Oct. 28, 2025, with a lead-plaintiff deadline set for March 9. The company remains under scrutiny as it shifts to SaaS subscriptions and faces a projected $30–$50 million 2026 revenue hit from government clients not converting.
24 February 2026
··
MongoDB stock drops again after 11% rout as tariffs, AI jitters loom ahead of March 2 earnings

MongoDB stock drops again after 11% rout as tariffs, AI jitters loom ahead of March 2 earnings

MongoDB shares fell 3.8% to $293.81 by 9:31 a.m. ET Tuesday, extending Monday’s 11.4% drop amid a broader selloff in software stocks. Investors cited uncertainty over tariffs and fears that new artificial intelligence tools could threaten parts of the software sector. MongoDB will report quarterly results after markets close on March 2. The S&P 500 software and services index is down nearly 24% year-to-date.
24 February 2026
······
Tenable stock price wobbles near 52-week lows as AI fears rattle cybersecurity names

Tenable stock price wobbles near 52-week lows as AI fears rattle cybersecurity names

Tenable shares closed down nearly 12% at $17.55 on Monday, hitting fresh 52-week lows after Anthropic launched an AI security tool targeting open-source code. The stock was little changed in premarket trading Tuesday, with heavy volume following the sector-wide selloff. Investors are watching for further moves at the open and a March 3 company presentation for signs of demand and competition.
24 February 2026
···
RingCentral stock steadies before the bell after 12% slide as Piper Sandler lifts target

RingCentral stock steadies before the bell after 12% slide as Piper Sandler lifts target

RingCentral shares rose 0.6% to $34.79 in premarket trading Tuesday after a 12.5% drop Monday and a 34% jump Friday. Piper Sandler raised its price target to $37 but kept a neutral rating, citing pricing pressure and dilution risk. The board approved a quarterly dividend of $0.075 per share, payable March 16 to holders as of March 9. Investors are watching if the post-earnings rally holds.
24 February 2026
··
IBM stock steadies before the bell after Anthropic’s COBOL AI claim sparks worst day since 2000

IBM stock steadies before the bell after Anthropic’s COBOL AI claim sparks worst day since 2000

IBM shares rose 0.7% in premarket trading Tuesday after plunging 13% Monday, their steepest drop since 2000. The selloff followed Anthropic’s claim that its Claude Code AI tools can speed up COBOL modernization, raising concerns over IBM’s mainframe services. IBM pushed back, saying platform modernization is more complex than code translation. Investors are watching IBM’s March 3 conference for further comments.
24 February 2026
···
Stoke Therapeutics stock swings premarket after Wolfe starts coverage with $40 target (STOK)

Stoke Therapeutics stock swings premarket after Wolfe starts coverage with $40 target (STOK)

Stoke Therapeutics shares dropped 1.2% to $35.80 in early premarket trading Tuesday, after a 5.7% gain the previous session. Wolfe Research began coverage with an “Outperform” rating and a $40 price target. Investors are watching for updates on the company’s Phase 3 Dravet syndrome trial with Biogen. About 21.6% of Stoke’s float is sold short, according to MarketBeat.
24 February 2026
···
IREN stock wobbles in premarket after Monday’s jump as MSCI rebalance nears

IREN stock wobbles in premarket after Monday’s jump as MSCI rebalance nears

IREN Limited shares fell 1.5% to $41.72 in premarket trading Tuesday, after jumping nearly 6% Monday ahead of its addition to the MSCI USA Index. Cantor Fitzgerald disclosed holdings of 3.47 million shares and put options on 5.03 million shares. Bitcoin dropped 5.3% to $62,693, pressuring crypto-linked stocks. IREN recently reported $2.8 billion in cash and secured $3.6 billion in GPU financing for a Microsoft contract.
24 February 2026
·
AngloGold Ashanti stock jumps 6% to a fresh high as gold swings and dividend dates come into focus

AngloGold Ashanti stock jumps 6% to a fresh high as gold swings and dividend dates come into focus

AngloGold Ashanti shares closed up 6% at $121.12 Monday after gold surged on U.S. tariff headlines, then slipped Tuesday as bullion prices fell over 1%. The company corrected a dividend date error, confirming March 13, 2026, as the record date. AngloGold recently reported a near tripling in annual profit and new reserves at its Nevada project.
24 February 2026
···
Equinox Gold stock swings as dividend and buyback plans collide with softer gold prices

Equinox Gold stock swings as dividend and buyback plans collide with softer gold prices

Equinox Gold shares closed up 6.25% in Toronto on Monday after the company declared its first quarterly dividend and applied for a share buyback. U.S.-listed shares last traded at $17.85, up about 6% after hours. The company reported net debt of $75 million at Jan. 31 after reducing debt by $1.1 billion since mid-2025. Gold prices fell over 1% on Tuesday, posing a near-term challenge for miners.
24 February 2026
···
NESR stock rises premarket as National Energy Services Reunited pushes into fresh 52-week highs

NESR stock rises premarket as National Energy Services Reunited pushes into fresh 52-week highs

NESR shares rose 2.5% to $26.70 in premarket trading Tuesday after a 6.8% jump the prior session, nearing the top of their 52-week range. The company reported Q4 revenue of $398.3 million and adjusted EPS of $0.32, beating estimates, but net income fell to $7.8 million due to impairment and restructuring charges. Management is scheduled to meet investors at conferences in Houston and Las Vegas.
24 February 2026
··
Dianthus Therapeutics (DNTH) stock rises ahead of TD Cowen conference; what investors watch next

Dianthus Therapeutics (DNTH) stock rises ahead of TD Cowen conference; what investors watch next

Dianthus Therapeutics shares rose 6.3% to $52.68 Monday ahead of CEO Marino Garcia’s scheduled fireside chat at TD Cowen’s health care conference on March 3. Volume reached about 944,000 shares. Investors are watching for updates on the company’s autoimmune pipeline and trial timelines. The event will be webcast and include one-on-one investor meetings.
24 February 2026
··
Bloom Energy stock slips before the open after 9% rally — here’s what traders are watching

Bloom Energy stock slips before the open after 9% rally — here’s what traders are watching

Bloom Energy shares fell 1.6% to $157.80 in premarket trading Tuesday after an 8.6% surge the previous session. Director Jeffrey Immelt disclosed gifting 4,000 shares in a late Monday SEC filing. Tariff uncertainty and Nvidia’s results this week are influencing AI-linked stock moves. Bloom’s 2026 revenue forecast stands at up to $3.3 billion, with a reported backlog of about $20 billion.
24 February 2026
··
1 … 211 212 213 214 215 … 1,953

Stock Market Today

  • Dr Martens Shares Rise on Profit Growth Amid Turnaround Signs
    May 19, 2026, 7:52 AM EDT. Dr Martens (LSE: DOCS) shares jumped nearly 6% after reporting a 61% rise in adjusted profit before tax (PBT) for fiscal year 2026, signaling a return to profit growth under CEO Ije Nwokorie. Despite an 84% share price drop since its 2021 IPO, the firm is shifting to a consumer-first model with strong brand collaborations and improved performance in the Americas. While management withheld specific guidance for FY27, analysts predict earnings growth could reduce the price-to-earnings ratio to 10 by 2028. The company maintains a 2.55p dividend, yielding 4%, reflecting cautious cash management amid supply chain cost controls. Investors are watching to see if this marks a sustainable turnaround for the iconic footwear brand.

Latest articles

MetaVia Stock Moves Ahead of the Open After Obesity-Drug Data Picked for ADA

MetaVia Stock Moves Ahead of the Open After Obesity-Drug Data Picked for ADA

19 May 2026
Diploma PLC shares rose 4.75% to 6,940p after the company raised its 2026 outlook, citing strong demand and a 17% rise in first-half revenue to £851.1 million. Adjusted operating profit climbed 33% to £208.9 million, and the interim dividend increased 5% to 19.1p. The Controls division posted 26% organic growth. Diploma completed 15 acquisitions worth about £310 million in the past year.
Zeta Global Pops Again as Traders Eye OpenAI Ad Deal

Zeta Global Pops Again as Traders Eye OpenAI Ad Deal

19 May 2026
Zeta Global shares rose 3.4% to $19.85 in premarket trading Tuesday after CEO David Steinberg announced an advertising agreement with OpenAI at a JPMorgan conference. The stock had closed up 11.6% at $19.19 on Monday, trading over 17 million shares. Bank of America reinstated coverage with a Buy rating and $24 target. Zeta recently reported first-quarter revenue up 50% year-over-year to $396 million.
Home Depot Earnings Show Housing Stress for Wall Street

Home Depot Earnings Show Housing Stress for Wall Street

19 May 2026
Home Depot reported first-quarter sales of $41.8 billion, up 4.8%, beating estimates, but comparable sales rose just 0.6%, missing analyst forecasts. Net earnings fell to $3.3 billion from $3.4 billion a year earlier. The company kept its 2026 outlook unchanged. Shares edged higher in premarket trading.

Popular

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.
Go toTop